BUZZ-U.S. STOCKS ON THE MOVE-Horizon Pharma, Catamaran, Teva, Alibaba
(For faster updates on individual market-movers, Eikon users please use search string "STXBZ US"; for the Day Ahead newsletter, link.reuters.com/mex49s; for the Morning News Call newsletter, link.reuters.com/nex49s) U.S. stocks opened higher on Monday as four M&A deals in the biotech sector lifted market sentiment after the worst weekly decline for the S&P 500 in two months. Dow Jones industrial average futures were up 1.46 percent at 17,884, S&P 500 futures were up 1.05 percent at 2,074 and Nasdaq 100 futures were up 0.98 percent at 4,368.
** CELLULAR DYNAMICS INTERNATIONAL INC, $16.45, +107.18 pct
Japan's Fujifilm Holdings Corp said on Monday it has agreed to acquire U.S. biotechnology firm Cellular Dynamics International Inc (CDI) for $307 million.
** HORIZON PHARMA PLC, $24.94, +14.35 pct
** HYPERION THERAPEUTICS INC, $46.05, +7.74 pct
Ireland's Horizon said it would buy the U.S. drugmaker for about $1.1 billion to add to its line-up of drugs that treat rare diseases. Horizon will pay $46 per share, a premium of 7.6 percent to Hyperion's Friday closing price.
** UNITEDHEALTH GROUP, $122.1, +3.47 pct Continued...